Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Combining and approaches, we elucidated the phoslactomycin post-PKS tailoring pathway in . Gene inactivation of - revealed seven phoslactomycin derivatives (four novel). Two cytochrome P450s were identified: PnT3 (mediating dual-site, multistep C-8/C-25 oxidation) and PnT7 (catalyzing C-18 hydroxylation). Activity evaluation established essential C-9 phosphate and detrimental ε-lactone/C-3 malonyl effects. These findings bridge the gap in phoslactomycin modification, highlighting a versatile P450 PnT3, and provide SAR foundations for PP2A inhibitor design.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/acs.orglett.5c03098 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Post-PKS Tailoring of Phoslactomycins Involving Two Cytochrome P450s.
Org Lett
September 2025
School of Chemistry and Materials Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.
Combining and approaches, we elucidated the phoslactomycin post-PKS tailoring pathway in . Gene inactivation of - revealed seven phoslactomycin derivatives (four novel). Two cytochrome P450s were identified: PnT3 (mediating dual-site, multistep C-8/C-25 oxidation) and PnT7 (catalyzing C-18 hydroxylation).
View Article and Find Full Text PDFA plug-and-play system for polycyclic tetramate macrolactam production and functionalization.
Microb Cell Fact
January 2025
Chair of Technical Biochemistry, Technische Universität Dresden, Bergstraße 66, 01069, Dresden, Germany.
Background: The biosynthesis of the natural product family of the polycyclic tetramate macrolactams (PoTeMs) employs an uncommon iterative polyketide synthase/non-ribosomal peptide synthetase (iPKS/NRPS). This machinery produces a universal PoTeM biosynthetic precursor that contains a tetramic acid moiety connected to two unsaturated polyene side chains. The enormous structural and hence functional diversity of PoTeMs is enabled by pathway-specific tailoring enzymes, particularly cyclization-catalyzing oxidases that process the polyene chains to form distinct ring systems, and further modifying enzymes.
View Article and Find Full Text PDFElucidation of the Late Steps during Hexacosalactone A Biosynthesis in Streptomyces samsunensis OUCT16-12.
Appl Environ Microbiol
March 2023
Key Laboratory of Marine Drugs, Ministry of Education of China, School of Medicine and Pharmacy, Ocean University of China, Qingdao, China.
Hexacosalactone A (1) is a polyene macrolide compound featuring a 2-amino-3-hydroxycyclopent-2-enone (CN)-fumaryl moiety. While compound 1 has been proposed to be assembled via a type I modular polyketide synthase (PKS) system, most of the putative biosynthetic steps lack experimental evidence. In this study, we elucidated the post-PKS tailoring steps of compound 1 through gene inactivation and biochemical assays.
View Article and Find Full Text PDFBiosynthetic pathway of peucemycin and identification of its derivative from Streptomyces peucetius.
Appl Microbiol Biotechnol
February 2023
Department of Life Science and Biochemical Engineering, Sun Moon University, 70 Sun Moon-Ro 221, Tangjeong-Myeon, Asan-Si, Chungnam, 31460, South Korea.
Streptomyces peucetius ATCC 27952 is a well-known producer of important anticancer compounds, daunorubicin and doxorubicin. In this study, we successfully identified a new macrolide, 25-hydroxy peucemycin, that exhibited an antibacterial effect on some pathogens. Based on the structure of a newly identified compound and through the inactivation of a polyketide synthase gene, we successfully identified its biosynthetic gene cluster which was considered to be the cryptic biosynthetic gene cluster.
View Article and Find Full Text PDFTwo strategies to improve the supply of PKS extender units for ansamitocin P-3 biosynthesis by CRISPR-Cas9.
Bioresour Bioprocess
August 2022
State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, 130 Meilong Road, Shanghai, 200237, China.
Ansamitocin P-3 (AP-3) produced by Actinosynnema pretiosum is a potent antitumor agent. However, lack of efficient genome editing tools greatly hinders the AP-3 overproduction in A. pretiosum.
View Article and Find Full Text PDF